US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

693.03

+4.110.60%

Number of Gainers:71

Number of Losers:69

Number of Flat:14

PE:- -

High:698.21

Open:689.82

Low:685.07

Close:688.92

Volume:272.16M

Turnover:8.90B

Market Cap:479.85B

Float Cap:365.12B

Loading ...

Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference

Solid Biosciences to Participate at Upcoming Investor Conferences

1stdibs.com Unveils 2026 AI-Driven Growth Roadmap

TScan Therapeutics Restructures to Focus on Solid Tumors

Robinhood initiated with an Outperform at Scotiabank

TScan Therapeutics Falls After Pausing Cancer Trial

NIQ Global Intelligence Working With Similarweb on AI Shopping Tracking Tool

MT Newswires Live

TScan Therapeutics - Expects to Complete Strategic Reorganization by End of Q4 2026 - SEC Filing

THOMSON REUTERS

TScan Therapeutics - CEO Gavin Macbeath Assumes Principal Financial and Accounting Officer Duties as of Sept 2, 2026 - SEC Filing

THOMSON REUTERS

TScan Therapeutics Inc - Expects to Incur About $4.1 Million in Employee-Related Costs, Consisting Primarily of Pay Continuation and Related Benefits

THOMSON REUTERS

TScan Therapeutics - Jason A. Amello, CFO, and Chrystal Louis, Cmo, Terminated Effective Sept 2, 2026 - SEC Filing

THOMSON REUTERS

TScan Therapeutics Inc - Expects That Substantially All of Reorg Charges Will Result in Future Cash Expenditures

THOMSON REUTERS

Sprinklr Q2 Revenue Inches Up, Slightly Misses Estimates

Sprinklr Shares Slip 5% Premarket After Co Forecasts FY27 Profit Below Estimates

THOMSON REUTERS

Sprinklr Q2 FY27 GAAP EPS Falls 40% to $0.03; Revenue Rises 1% to $213.7 Million

Sprinklr Inc Q3 Shr View $0.13, REV View $216.3 Mln

THOMSON REUTERS

Sprinklr Q2 Revenue USD 213.743 Million VS. Ibes Estimate USD 214.4 Million

THOMSON REUTERS

Sprinklr Q2 EPS USD 0.03

THOMSON REUTERS

Sprinklr Outlook FY Non-Gaap Net Income Per Share of Approximately $0.47

THOMSON REUTERS

Sprinklr Announces Second Quarter Fiscal 2027 Results

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BK4539/news?page=35"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":693.02655,"timestamp":1789156799999,"preClose":688.91504,"halted":0,"volume":272157313,"delay":0,"changeRate":0.005968,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":4.111511,"latestTime":"09-11 16:00:00 EDT","open":689.8237,"high":698.2087,"low":685.0665,"amount":8901943117.280722,"amplitude":0.019077,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.322141,"peRate":139.801509,"turnoverRate":0.021443,"increases":71,"decrements":69,"flats":10,"marketCap":479852364396.5,"floatMarketCap":365120021896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":698.2087,"amplitude":0.019077,"preClose":688.91504,"low":685.0665,"pbRate":"5.322141","latestPrice":693.02655,"volume":272157313,"delay":0,"open":689.8237,"prevYearClose":881.5255,"prevWeekClose":725.2816,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":733.4782,"twentyDayClose":682.8836,"sixtyDayClose":729.1859,"secType":"PLATE","market":"US","turnoverRate":0.021443,"peRate":139.801509,"marketCap":479852364396.5,"floatMarketCap":365120021896,"timestamp":1789156799999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":71,"down":69,"flat":14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:35,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664819044","title":"Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819044","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819044?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355100/0/en/design-therapeutics-to-participate-in-2026-cantor-fitzgerald-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","LU0029874061.USD","DSGN","BK4505","XLV","BK4139","XBI","BK4581","BK4585","HCSG","LABU","BK4539","BK4588","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664071819","title":"Solid Biosciences to Participate at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664071819","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664071819?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"CHARLESTOWN, Mass., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355087/0/en/solid-biosciences-to-participate-at-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLDB","FA","BK4130","BK4539","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664281911","title":"1stdibs.com Unveils 2026 AI-Driven Growth Roadmap","url":"https://stock-news.laohu8.com/highlight/detail?id=2664281911","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664281911?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:59","pubTimestamp":1788350398,"startTime":"0","endTime":"0","summary":"1stdibs.com ( ($DIBS) ) has shared an announcement. On September 2, 2026, 1stdibs.com posted an updated investor presentation outlining its 2026 pr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/1stdibs-com-unveils-2026-ai-driven-growth-roadmap?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/1stdibs-com-unveils-2026-ai-driven-growth-roadmap?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4122","AGIX","BK4539","CHAT","DIBS","ARTY","QTOC","BK4220","VTHR","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819124","title":"TScan Therapeutics Restructures to Focus on Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819124","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819124?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:59","pubTimestamp":1788350350,"startTime":"0","endTime":"0","summary":"The latest update is out from TScan Therapeutics ( ($TCRX) ). On September 2, 2026, TScan Therapeutics announced a strategic reorganization that sh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tscan-therapeutics-restructures-to-focus-on-solid-tumors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tscan-therapeutics-restructures-to-focus-on-solid-tumors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","BK4539","TCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664281949","title":"Robinhood initiated with an Outperform at Scotiabank","url":"https://stock-news.laohu8.com/highlight/detail?id=2664281949","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664281949?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:55","pubTimestamp":1788350158,"startTime":"0","endTime":"0","summary":"Scotiabank initiated coverage of Robinhood (HOOD) with an Outperform rating and $136 price target Published first on TheFly – the ultimate source f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/robinhood-initiated-with-an-outperform-at-scotiabank-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/robinhood-initiated-with-an-outperform-at-scotiabank-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","BK4547","ROBN","HOOW","BLCK","HOOI","HOOG","BPAY","HOYY","HOOZ","FINX","IAI","HOII","HOOD","HOOX","LU1861558580.USD","HOOC","BK4127","HODU","HOOY","BK4539","CRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819619","title":"TScan Therapeutics Falls After Pausing Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819619","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819619?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:55","pubTimestamp":1788350101,"startTime":"0","endTime":"0","summary":"BUZZ-TScan Therapeutics falls after pausing cancer trial** Shares of drug developer TScan TherapeuticsTCRX.Ofall 9.9% to 60 cents premarket** TCRX pauses enrollment in a late-stage trial of experiment","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U105:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","TCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664816676","title":"NIQ Global Intelligence Working With Similarweb on AI Shopping Tracking Tool","url":"https://stock-news.laohu8.com/highlight/detail?id=2664816676","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664816676?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:27","pubTimestamp":1788348476,"startTime":"0","endTime":"0","summary":"NIQ Global Intelligence  and Similarweb  are building a tracking service to monitor how artificial intelligence software influences online consumer purchases, NIQ said Wednesday.The joint platform will combine retail sales metrics with digital traffic records to trace the shopping process within generative AI applications.An initial version of the software is scheduled to launch for specific markets in Q4, the company said.Shares of NIQ were down more than 1% pre-bell Wednesday, while Similarweb gained over 3%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NIQ","CHAT","BK4539","QTOC","VTHR","AIPO","BK4009","BK4023","SMWB","AGIX","QQH","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664816656","title":"TScan Therapeutics - Expects to Complete Strategic Reorganization by End of Q4 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664816656","media":"THOMSON REUTERS","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664816656?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:23","pubTimestamp":1788348213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T17W:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TCRX","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664816634","title":"TScan Therapeutics - CEO Gavin Macbeath Assumes Principal Financial and Accounting Officer Duties as of Sept 2, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664816634","media":"THOMSON REUTERS","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664816634?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:23","pubTimestamp":1788348213,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T17W:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","TCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664816501","title":"TScan Therapeutics Inc - Expects to Incur About $4.1 Million in Employee-Related Costs, Consisting Primarily of Pay Continuation and Related Benefits","url":"https://stock-news.laohu8.com/highlight/detail?id=2664816501","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664816501?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:23","pubTimestamp":1788348213,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T17W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","TCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664504816","title":"TScan Therapeutics - Jason A. Amello, CFO, and Chrystal Louis, Cmo, Terminated Effective Sept 2, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664504816","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664504816?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:23","pubTimestamp":1788348213,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T17W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TCRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664166318","title":"TScan Therapeutics Inc - Expects That Substantially All of Reorg Charges Will Result in Future Cash Expenditures","url":"https://stock-news.laohu8.com/highlight/detail?id=2664166318","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664166318?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:23","pubTimestamp":1788348213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T17W:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","TCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664816836","title":"Sprinklr Q2 Revenue Inches Up, Slightly Misses Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2664816836","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664816836?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:14","pubTimestamp":1788347668,"startTime":"0","endTime":"0","summary":"Sprinklr Q2 revenue inches up, slightly misses estimatesOverviewCustomer experience software firm's Q2 revenue grew 1% yr/yr, slightly missing analyst expectationsAdjusted EPS for Q2 beat analyst expe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL1N44U0GH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1923623000.USD","BK4097","CXM","PALD","WCLD","LU0154245673.USD","LU1720051017.SGD","LU0154245756.USD","BK4608","LU0823421416.USD","LU2210150020.SGD","IE00B19Z9505.USD","IE00B19Z8X17.USD","BK4116","LU0353189680.USD","LU1720051108.HKD","BK4598","MDB","LU2095319765.USD","MDBX","PANW","LU1712237335.SGD","CIBR","LU1989764664.SGD","WCBR","IE00B19Z8W00.USD","LU0823434740.USD","CLOD","BK4539","IGV","SG9999001424.SGD","LU2272731600.USD","AIFD","LU1169589451.USD","LU2106854487.HKD","IE00BMPRXR70.SGD","BUG","LU2286300806.USD","IHAK","LU1804176565.USD","BK4532","PALU","LU0719512351.SGD","HAKY","LU1917777945.USD","PANG","LU1548497426.USD","PSWD","LU1989764748.USD","SPAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664081502","title":"Sprinklr Shares Slip 5% Premarket After Co Forecasts FY27 Profit Below Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2664081502","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664081502?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:12","pubTimestamp":1788347537,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U0Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4023","CXM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664152688","title":"Sprinklr Q2 FY27 GAAP EPS Falls 40% to $0.03; Revenue Rises 1% to $213.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664152688","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664152688?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:06","pubTimestamp":1788347167,"startTime":"0","endTime":"0","summary":"Sprinklr Q2 FY27 GAAP EPS falls 40% to $0.03; revenue rises 1% to $213.7 millionSprinklr posted Q2 fiscal 2027 revenue of USD 213.7 million, up 1% year-over-year; GAAP operating income fell to USD 10 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL476mvr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CXM","BK4539","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664981527","title":"Sprinklr Inc Q3 Shr View $0.13, REV View $216.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2664981527","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664981527?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:05","pubTimestamp":1788347101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nPLX1NX019:12","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CXM","BK4539","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881542","title":"Sprinklr Q2 Revenue USD 213.743 Million VS. Ibes Estimate USD 214.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881542","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881542?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:05","pubTimestamp":1788347101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nPLX1NX019:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CXM","BK4023","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815429","title":"Sprinklr Q2 EPS USD 0.03","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815429","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815429?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:05","pubTimestamp":1788347101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nPLX1NX019:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CXM","BK4023","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664276815","title":"Sprinklr Outlook FY Non-Gaap Net Income Per Share of Approximately $0.47","url":"https://stock-news.laohu8.com/highlight/detail?id=2664276815","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664276815?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:05","pubTimestamp":1788347101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nPLX1NX019:11","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4023","CXM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664421815","title":"Sprinklr Announces Second Quarter Fiscal 2027 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2664421815","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664421815?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:05","pubTimestamp":1788347100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA9WTVQR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4023","CXM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":45,"pageCount":35,"totalSize":898,"code":"91000000","status":"200"}]}}